About the Study

Do you experience the negative symptoms of schizophrenia?

You are not alone. Nearly 60% of people with schizophrenia experience at least one negative symptom, such as lack of motivation or limited interaction with other people. However, many medications prescribed for schizophrenia do not effectively treat negative symptoms. This study will access the safety and effectiveness of a new medication to treat negative symptoms of schizophrenia. By participating in this study, you will help us learn more about the new medication, which could one day help many people experiencing negative symptoms due to schizophrenia. This study is sponsored by Avanir Pharmaceuticals.

Length of Study: 15 weeks 

Eligibility 

You may be eligible to participate in this study if you:

• are between the ages of 18-60
• have been diagnosed with schizophrenia
• are currently taking medication for schizophrenia
• have been experiencing negative symptoms for at least 6 months

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed.

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 116 today. You can also fill out the contact form below.